1. Stimwave, a medical device company, was found to have engaged in a fraudulent scheme to sell fake pain implant devices. The company's former CEO, Laura Tyler Perryman, was sentenced to 42 months in prison for her role in the scheme, which involved falsely marketing the devices as FDA-approved and bilking millions of dollars from Medicare and private insurers.

2. The Stimwave case highlights the ongoing problem of fraud and deception in the medical device industry. Perryman and her co-conspirators allegedly used a range of tactics to mislead healthcare providers and patients, including forging documents, creating fake websites, and making false claims about the devices' effectiveness and safety.

3. The case serves as a cautionary tale for the importance of regulatory oversight and consumer vigilance in the healthcare industry. Experts warn that similar schemes may be occurring elsewhere, underscoring the need for stronger enforcement and transparency measures to protect patients and the integrity of the medical system.